1. Home
  2. TMDX vs COTY Comparison

TMDX vs COTY Comparison

Compare TMDX & COTY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TMDX
  • COTY
  • Stock Information
  • Founded
  • TMDX 1998
  • COTY 1904
  • Country
  • TMDX United States
  • COTY United States
  • Employees
  • TMDX N/A
  • COTY N/A
  • Industry
  • TMDX Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • COTY Package Goods/Cosmetics
  • Sector
  • TMDX Health Care
  • COTY Consumer Discretionary
  • Exchange
  • TMDX Nasdaq
  • COTY Nasdaq
  • Market Cap
  • TMDX 4.8B
  • COTY 4.4B
  • IPO Year
  • TMDX 2019
  • COTY 2013
  • Fundamental
  • Price
  • TMDX $120.31
  • COTY $4.91
  • Analyst Decision
  • TMDX Buy
  • COTY Buy
  • Analyst Count
  • TMDX 9
  • COTY 15
  • Target Price
  • TMDX $129.88
  • COTY $7.43
  • AVG Volume (30 Days)
  • TMDX 1.0M
  • COTY 7.5M
  • Earning Date
  • TMDX 07-30-2025
  • COTY 08-20-2025
  • Dividend Yield
  • TMDX N/A
  • COTY N/A
  • EPS Growth
  • TMDX N/A
  • COTY N/A
  • EPS
  • TMDX 1.41
  • COTY N/A
  • Revenue
  • TMDX $488,227,000.00
  • COTY $6,003,900,000.00
  • Revenue This Year
  • TMDX $34.07
  • COTY N/A
  • Revenue Next Year
  • TMDX $20.76
  • COTY $1.19
  • P/E Ratio
  • TMDX $76.58
  • COTY N/A
  • Revenue Growth
  • TMDX 64.43
  • COTY N/A
  • 52 Week Low
  • TMDX $55.00
  • COTY $4.46
  • 52 Week High
  • TMDX $177.37
  • COTY $10.30
  • Technical
  • Relative Strength Index (RSI)
  • TMDX 52.35
  • COTY 47.44
  • Support Level
  • TMDX $104.71
  • COTY $4.89
  • Resistance Level
  • TMDX $110.00
  • COTY $5.15
  • Average True Range (ATR)
  • TMDX 5.69
  • COTY 0.16
  • MACD
  • TMDX 0.32
  • COTY -0.00
  • Stochastic Oscillator
  • TMDX 74.25
  • COTY 34.15

About TMDX TransMedics Group Inc.

TransMedics Group Inc is a commercial-stage medical technology company transforming organ transplant therapy for end-stage organ failure patients across multiple disease states. It has developed the Organ Care System(OCS) to comprehensively address the limitations of cold storage. The OCS is a portable organ perfusion, optimization and monitoring system that utilizes technology to replicate near-physiologic conditions for donor organs outside of the human body. The Company has developed and is commercializing a proprietary system to preserve and deliver human organs for transplant in a near-physiologic condition to address the limitations of cold storage organ preservation.

About COTY Coty Inc.

Coty is a global beauty maker that focuses on fragrance (59% of sales) and color cosmetics (28%), with limited exposure to skincare (5%) and body care (8%). For the fragrance business, Coty licenses luxury and high-end brands including Gucci, Burberry, Hugo Boss, Davidoff, and Calvin Klein, while its consumer cosmetics business focuses on acquired mass brands such as CoverGirl, Max Factor, Rimmel, Sally Hansen, and Bourjois. It also collaborates with social media celebrity Kylie Jenner to launch makeup products bearing her name. By region, Coty generates close to 44% of sales from Europe, 42% from the Americas, and 14% from Asia-Pacific. German investment firm JAB is a controlling shareholder, with a 53% stake.

Share on Social Networks: